Towa Pharmaceutical Co (JP:4553) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Towa Pharmaceutical Co., Ltd. has reached a settlement in a patent infringement lawsuit filed by Eagle Pharmaceuticals, Inc. and SymBio Pharmaceuticals Limited concerning two of its intravenous infusion products. The lawsuit, initiated in December 2022, has been resolved with undisclosed terms, and Towa Pharmaceutical will continue to manufacture and sell the products with minimal impact on its consolidated financial results.
For further insights into JP:4553 stock, check out TipRanks’ Stock Analysis page.